Filing Details

Accession Number:
0001144204-17-015872
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-21 16:47:06
Reporting Period:
2017-03-13
Filing Date:
2017-03-21
Accepted Time:
2017-03-21 16:47:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1372514 Eyegate Pharmaceuticals Inc EYEG Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604072 Ii Capital Ventech 47 Avenue De L'Opera
Paris I0 75002
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-03-13 4,419 $2.80 1,431,814 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.78 to $2.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.